ROC Inc.

Ride for Research 2024: Join the Cause Today!

Ride for Research 2024 is an upcoming event for ROC Inc and lead by board member Peter Reaburn. The event aims to raise vital funds and awareness for rare ovarian cancer research. The team of 30 riders will cycle for over five consecutive days starting from March 18th, 2024 in Bright Victoria. Currently, they have raised $83,000 out of their $200,000 goal with only 70 days left. Donating to one of the riders and providing words of encouragement is a great way to show support and make a difference. Join the cause and help make a positive impact!

ROC Inc Ride 4 Research March 18-22 March 2024 Call out for riders to join in

Come join our unique event in beautiful Bright, Victoria 18-22 March 2024. An unforgettable experience! This ride is not only about the joy of cycling, but also about supporting a meaningful cause to raise money to support rare ovarian cancer awareness and research. Choose to do a challenging road ride one day, a scenic rail trail the next. The choice is yours. Check out our website for details: https://www.rocinc.org.au/ride-for-research/ The 2024 ROC Inc Ride 4 Research raises money for Rare Ovarian Cancer awareness and research Together, we are raising funds to make a positive impact in our community and beyond. […]

Rare Ovarian Cancer researchers and consumers work together to produce a research paper.

Congratulations to ALL of the authors, lead author Professor Victoria White from Deakin University, Professor Peter Fuller, Associate Professor Simon Chu, Maria Alexiadia, All from the Hudson Institute of Medical Research, Professor Thomas Jobling from Monash Health, Members from the GCT Survivor Sister Facebook Group our Founder and CEO of ROC Inc Natasha Armour (from Australia), Linda Langdale (from the UK), Sue Rogers, Kaye Ackermann and Kim Eroh (all from the USA), on having your research paper published in the journal Cancer – an international interdisciplinary journal of the American Cancer Society https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.34767 You should ALL feel proud of your […]

Claire’s Swimathon, taking the plunge for Rare Ovarian Cancer research

80 swimmers and over $15,000 raised for research into rare ovarian cancer. ROC Inc Swim for Claire was hosted by Gold Coast’s Miami Masters Swim Club at the Miami Aquatic Centre. A fun-filled and very social event with many laps covered. Juvenile Granulosa Cell Tumour (JGCT) survivor Claire Reaburn, and national masters record holder swam with her daughter Rebecca Who swam 3 km and husband Peter 60 x 50m on 60s. Awareness information handed out and many more females understanding of the signs and symptoms of ovarian cancer. A big thank you to every swimmer, every donor, every supporter and […]

GCT Ovarian Cancer Research Funded by YOU!

Congratulation and thank you to everyone that has helped raise our target of $30,000 for ovarian cancer research. The $30,000 raised is going to champion world class Granulosa Cell Tumour researchers Dr Simon Chu and Professor Peter Fuller and their team at the Hudson Institute of Medical Research for Whole Genome Sequencing of GCT tumour samples. GCT a rare ovarian cancer that has two sub types adult GCT (aGCT) and juvenile GCT (jGCT). A first for jGCT research. This research will impact so many lives. There is currently very little known about GCT and only research will help to change […]

Peter will be riding for his wife Claire to raise funds for vital ovarian cancer research

Looking for FEMALE CYCLISTS wanting a challenge. One aiming to raise over $100,000 for ROC Inc. to encourage more research into Rare Ovarian Cancers. My wife, Claire, and mother of our two daughters Rebecca (29) and Megan (26) has Juvenile Granulosa Cell Tumour (JGCT). As you know, so little is known about Granulosa Cell Tumour (GCT). We are looking to ride road bikes from Canberra to Melbourne next April-May. We are looking for riders to join us. See details on the image below. We need a commitment by October 30 this year to engage with the ride. PM me or […]